{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:27:04Z","timestamp":1782912424831,"version":"3.54.5"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2016,2,23]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              The subcutaneous implantable cardioverter defibrillator (S\u2010\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              ) has been developed to avert risks associated with transvenous defibrillator leads. The technology is attractive for younger patients, such as those with hypertrophic cardiomyopathy (HCM). However, there are limited data on S\u2010\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              use in\n              <jats:styled-content style=\"fixed-case\">HCM<\/jats:styled-content>\n              .\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              <jats:styled-content style=\"fixed-case\">HCM<\/jats:styled-content>\n              patients identified at risk for sudden death were considered for S\u2010\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              implantation. Patients were screened for potential oversensing by surface electrocardiography (ECG). At implant, defibrillation threshold (\n              <jats:styled-content style=\"fixed-case\">DFT<\/jats:styled-content>\n              ) testing was performed at 65, 50, and 35 joules (J). Twenty\u2010seven patients were considered for S\u2010\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              implantation, and after screening, 23 (85%) remained eligible. The presence of a bundle branch block was associated with screening failure, whereas elevated body mass index (BMI) showed a trend toward association. One patient passed screening at rest, but failed with an\n              <jats:styled-content style=\"fixed-case\">ECG<\/jats:styled-content>\n              obtained after exercise. At implant, the S\u2010\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              terminated ventricular fibrillation (\n              <jats:styled-content style=\"fixed-case\">VF<\/jats:styled-content>\n              ) with a 65J shock in all 15 implanted patients and a 50J shock was successful in 12 of 15. A 35J shock terminated\n              <jats:styled-content style=\"fixed-case\">VF<\/jats:styled-content>\n              in 10 of 12 patients.\n              <jats:styled-content style=\"fixed-case\">DFT<\/jats:styled-content>\n              failure at 50\u00a0J was associated with a higher\n              <jats:styled-content style=\"fixed-case\">BMI<\/jats:styled-content>\n              . There were no appropriate shocks after a median follow\u2010up of 17.5 (3\u201335) months, and 1 patient received an inappropriate shock attributable to a temporary reduction in\n              <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n              amplitude while bending forward, resulting in oversensing, despite successful screening.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              In a high\u2010risk\n              <jats:styled-content style=\"fixed-case\">HCM<\/jats:styled-content>\n              cohort without a pacing indication referred for consideration of an\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              , the majority were eligible for S\u2010\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              . The S\u2010\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              is effective at recognizing and terminating\n              <jats:styled-content style=\"fixed-case\">VF<\/jats:styled-content>\n              at implant with a wide safety margin.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.115.002488","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T13:11:36Z","timestamp":1536930696000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":56,"title":["Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience"],"prefix":"10.1161","volume":"5","author":[{"given":"Jonathan","family":"Weinstock","sequence":"first","affiliation":[{"name":"Cardiac Arrhythmia Center and The Hypertrophic Cardiomyopathy Center, Tufts Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef H.","family":"Bader","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center and The Hypertrophic Cardiomyopathy Center, Tufts Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center and The Hypertrophic Cardiomyopathy Center, Tufts Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan J.","family":"Rowin","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center and The Hypertrophic Cardiomyopathy Center, Tufts Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Link","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Center and The Hypertrophic Cardiomyopathy Center, Tufts Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.05.003"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200002103420601"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.01.037"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.06.011"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2009.01683.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003042"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu112"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2010.02843.x"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-012-0297-3"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.04.025"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12343"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut370"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.130.suppl_2.12223"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960240313"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.975219"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.053744"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.115.002488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:24:30Z","timestamp":1715595870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.115.002488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2,23]]}},"alternative-id":["10.1161\/JAHA.115.002488"],"URL":"https:\/\/doi.org\/10.1161\/jaha.115.002488","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]},"assertion":[{"value":"2015-08-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-02-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e002488"}}